28 research outputs found
SARS-CoV-2 reverse zoonoses to pumas and lions, South Africa
SUPPLEMENTARY MATERIAL : TABLE S1: PCR and serological results from direct and indirect human contacts with infected lions, TABLE S2: Detection of SARS-CoV-2 E and RdRp genes from lion faecal samples in Ct values, FIGURE S1: Bayesian phylogenetic inference of whole genome sequences detected in lions and humans.Reverse-zoonotic infections of severe acute respiratory syndrome-related coronavirus 2
(SARS-CoV-2) from humans to wildlife species internationally raise concern over the emergence of
new variants in animals. A better understanding of the transmission dynamics and pathogenesis in
susceptible species will mitigate the risk to humans and wildlife occurring in Africa. Here we report
infection of an exotic puma (July 2020) and three African lions (July 2021) in the same private zoo
in Johannesburg, South Africa. One Health genomic surveillance identified transmission of a Delta
variant from a zookeeper to the three lions, similar to those circulating in humans in South Africa.
One lion developed pneumonia while the other cases had mild infection. Both the puma and lions
remained positive for SARS-CoV-2 RNA for up to 7 weeks.The G7 Global Health fund supplementary funding for SARS-CoV-2 through the Robert Koch Institute for the African Network for improved diagnostics and epidemiology of common and emerging infections.https://www.mdpi.com/journal/virusesam2023Centre for Veterinary Wildlife StudiesMedical VirologyProduction Animal Studie
Genetic characterisation of South African and Mozambican bovine rotaviruses reveals a typical bovine-like artiodactyl constellation derived through multiple reassortment events
This study presents whole genomes of seven bovine rotavirus strains from South Africa
and Mozambique. Double-stranded RNA, extracted from stool samples without prior adaptation to
cell culture, was used to synthesise cDNA using a self-annealing anchor primer ligated to dsRNA
and random hexamers. The cDNA was subsequently sequenced using an Illumina MiSeq platform
without prior genome amplification. All strains exhibited bovine-like artiodactyl genome constellations (G10/G6-P[11]/P[5]-I2-R2-C2-M2-A3/A11/A13-N2-T6-E2-H3). Phylogenetic analysis revealed
relatively homogenous strains, which were mostly related to other South African animal strains or
to each other. It appears that these study strains represent a specific bovine rotavirus population
endemic to Southern Africa that was derived through multiple reassortment events. While one
Mozambican strain, MPT307, was similar to the South African strains, the second strain, MPT93, was
divergent from the other study strains, exhibiting evidence of interspecies transmission of the VP1
and NSP2 genes. The data presented in this study not only contribute to the knowledge of circulating
African bovine rotavirus strains, but also emphasise the need for expanded surveillance of animal
rotaviruses in African countries in order to improve our understanding of rotavirus strain diversity.Deutsche Forschungsgemeinschaft (DFG);
European Foundation Initiative for African Research into Neglected Tropical Diseases (EFINTD);
South African Medical Research Council (SAMRC);
Australian National Health and Medical Research Council.http://www.mdpi.com/journal/pathogenspm2022Medical Virolog
Recommended from our members
Health comorbidities and cognitive abilities across the lifespan in Down syndrome
Abstract: Background: Down syndrome (DS) is associated with variable intellectual disability and multiple health and psychiatric comorbidities. The impact of such comorbidities on cognitive outcomes is unknown. We aimed to describe patterns of physical health and psychiatric comorbidity prevalence, and receptive language ability, in DS across the lifespan, and determine relationships with cognitive outcomes. Methods: Detailed medical histories were collected and cognitive abilities measured using standardised tests for 602 individuals with DS from England and Wales (age range 3 months to 73 years). Differences in prevalence rates between age groups and between males and females were determined using chi-squared or Fisher’s exact tests. In adults, rates for psychiatric comorbidities were compared to expected population rates using standardised morbidity ratios (SMRs). Adapted ANCOVA functions were constructed to explore age and sex associations with receptive language ability across the lifespan, and regression analyses were performed to determine whether the presence of health comorbidities or physical phenotypes predicted cognitive abilities. Results: Multiple comorbidities showed prevalence differences across the lifespan, though there were few sex differences. In adults, SMRs were increased in males and decreased in females with DS for schizophrenia, bipolar disorder, and anxiety. Further, SMRs were increased in both males and females with DS for dementia, autism, ADHD, and depression, with differences more pronounced in females for dementia and autism, and in males for depression. Across the lifespan, receptive language abilities increasingly deviated from age-typical levels, and males scored poorer than females. Only autism and epilepsy were associated with poorer cognitive ability in those aged 16–35 years, with no relationships for physical health comorbidities, including congenital heart defects. Conclusions: Our results indicate the prevalence of multiple comorbidities varies across the lifespan in DS, and in adults, rates for psychiatric comorbidities show different patterns for males and females relative to expected population rates. Further, most health comorbidities are not associated with poorer cognitive outcomes in DS, apart from autism and epilepsy. It is essential for clinicians to consider such differences to provide appropriate care and treatment for those with DS and to provide prognostic information relating to cognitive outcomes in those with comorbidities
Recommended from our members
Health comorbidities and cognitive abilities across the lifespan in Down syndrome
Abstract: Background: Down syndrome (DS) is associated with variable intellectual disability and multiple health and psychiatric comorbidities. The impact of such comorbidities on cognitive outcomes is unknown. We aimed to describe patterns of physical health and psychiatric comorbidity prevalence, and receptive language ability, in DS across the lifespan, and determine relationships with cognitive outcomes. Methods: Detailed medical histories were collected and cognitive abilities measured using standardised tests for 602 individuals with DS from England and Wales (age range 3 months to 73 years). Differences in prevalence rates between age groups and between males and females were determined using chi-squared or Fisher’s exact tests. In adults, rates for psychiatric comorbidities were compared to expected population rates using standardised morbidity ratios (SMRs). Adapted ANCOVA functions were constructed to explore age and sex associations with receptive language ability across the lifespan, and regression analyses were performed to determine whether the presence of health comorbidities or physical phenotypes predicted cognitive abilities. Results: Multiple comorbidities showed prevalence differences across the lifespan, though there were few sex differences. In adults, SMRs were increased in males and decreased in females with DS for schizophrenia, bipolar disorder, and anxiety. Further, SMRs were increased in both males and females with DS for dementia, autism, ADHD, and depression, with differences more pronounced in females for dementia and autism, and in males for depression. Across the lifespan, receptive language abilities increasingly deviated from age-typical levels, and males scored poorer than females. Only autism and epilepsy were associated with poorer cognitive ability in those aged 16–35 years, with no relationships for physical health comorbidities, including congenital heart defects. Conclusions: Our results indicate the prevalence of multiple comorbidities varies across the lifespan in DS, and in adults, rates for psychiatric comorbidities show different patterns for males and females relative to expected population rates. Further, most health comorbidities are not associated with poorer cognitive outcomes in DS, apart from autism and epilepsy. It is essential for clinicians to consider such differences to provide appropriate care and treatment for those with DS and to provide prognostic information relating to cognitive outcomes in those with comorbidities
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or infection. However,
whether Omicron triggers cross-reactive humoral responses to other variants of concern (VOCs) remains unknown.
We used plasma from 20 unvaccinated and 7 vaccinated individuals infected by Omicron BA.1 to test
binding, Fc effector function, and neutralization against VOCs. In unvaccinated individuals, Fc effector function
and binding antibodies targeted Omicron and other VOCs at comparable levels. However, Omicron BA.1-
triggered neutralization was not extensively cross-reactive for VOCs (14- to 31-fold titer reduction), and we
observed 4-fold decreased titers against Omicron BA.2. In contrast, vaccination followed by breakthrough
Omicron infection associated with improved cross-neutralization of VOCs with titers exceeding 1:2,100.
This has important implications for the vulnerability of unvaccinated Omicron-infected individuals to reinfection
by circulating and emerging VOCs. Although Omicron-based immunogens might be adequate boosters,
they are unlikely to be superior to existing vaccines for priming in SARS-CoV-2-naive individuals.The South African Research Chairs Initiative of the Department of Science and Innovation, the National Research Foundation of South Africa, the South African Medical Research Council Strategic Health Innovation Partnerships (SHIP) program, the Centre for the AIDS Programme of Research in South Africa (CAPRISA), the Bill and Melinda Gates Foundation through the Global Immunology and Immune Sequencing for Epidemic Response (GIISER) program and L’Oreal/UNESCO Women in Science South Africa Young Talents award.http://www.cell.com/cell-host-microbe/homeam2023ImmunologyMedical Virolog
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in southern Africa has been characterised by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, whilst the second and third waves were driven by the Beta and Delta variants, respectively1-3. In November 2021, genomic surveillance teams in South Africa and Botswana detected a new SARS-CoV-2 variant associated with a rapid resurgence of infections in Gauteng Province, South Africa. Within three days of the first genome being uploaded, it was designated a variant of concern (Omicron) by the World Health Organization and, within three weeks, had been identified in 87 countries. The Omicron variant is exceptional for carrying over 30 mutations in the spike glycoprotein, predicted to influence antibody neutralization and spike function4. Here, we describe the genomic profile and early transmission dynamics of Omicron, highlighting the rapid spread in regions with high levels of population immunity
TRY plant trait database – enhanced coverage and open access
Plant traits - the morphological, anatomical, physiological, biochemical and phenological characteristics of plants - determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait‐based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits - almost complete coverage for ‘plant growth form’. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait–environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
INTRODUCTION
Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic.
RATIONALE
We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs).
RESULTS
Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants.
CONCLUSION
Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century
Phylogeny and molecular identification of Cronobacter strains isolated from south African food products
Thesis (MSc Food Sc)--University of Stellenbosch, 2011.ENGLISH ABSTRACT: The genus Cronobacter (Enterobacter sakazakii) contains opportunistic pathogens that can
cause a severe form of neonatal meningitis, necrotising enterocolitis and septicaemia.
Cronobacter infections have been reported in all age groups, however, immunocompromised
infants are more susceptible to these infections. Furthermore, Cronobacter
strains have been reported to show differences in sensitivity to antibiotics and virulence.
These differences led to the reclassification of Cronobacter and currently the genus
contains five distinct species, namely Cronobacter sakazakii, Cronobacter malonaticus,
Cronobacter turicensis, Cronobacter dublinensis and Cronobacter muytjensii. As this
reclassification was only accepted recently, there are not many typing methods optimised
for differentiation between the five Cronobacter species. Typing of Cronobacter strains are
important as the species may be diverse regarding their virulence.
Cronobacter strains have been isolated from infant formula milk (IFM), the
environment of an IFM processing facility and fresh produce in South Africa. However,
little is known about the phylogeny and prevalence of these strains. The aim of this study
was to classify 24 South African Cronobacter strains (previously identified as E. sakazakii)
and to evaluate the phylogeny of the isolates based on the 16S ribosomal RNA (rRNA) and
rpoA genes. All 24 South African strains were identified as Cr. sakazakii despite a wide
variety of isolation sources. Other studies have also found that irrespective of the isolation
source, the majority of Cronobacter strains are identified as Cr. sakazakii. The South
African strains were found to be phylogenetically closely related. However, two distinct
clusters separated at a 93 % confidence level were observed in the Cr. sakazakii group
based on the 16S rRNA gene analysis.
Strains of Cr. sakazakii, Cr. dublinensis, Cr. turicensis and Cr. muytjensii were
differentiated from each other with sequence data of the 16S rRNA and rpoA genes, but it
was not possible to differentiate between Cr. sakazakii and Cr. malonaticus. The
phylogram based on the rpoA gene sequences did separate Cr. malonaticus and Cr.
sakazakii strains, however, the clusters were separated with a low bootstrap value of 70 %.
Phylogenetic analysis based on the rpoA and 16S rRNA genes were, therefore, not
sufficient to distinguish between all the Cronobacter species. The sequence data of these
two genes can be used to differentiate between the Cronobacter strains when used in
combination with malonate utilisation analysis.
A PCR-RFLP method was subsequently developed to facilitate the simultaneous
differentiation between all five Cronobacter species. The PCR-RFLP assay was based on
the amplification of the rpoB gene followed by the combined digestion with restriction
endonucleases Csp6I and HinP1I. Unique profiles for each of the five Cronobacter species
were obtained and it was also possible to differentiate between Enterobacteriaceae and
Cronobacter strains. Furthermore, two strains which were identified as Cr. sakazakii with
sequencing based on the 16S rRNA and rpoA genes had PCR-RFLP profiles identical to
that of Cr. malonaticus. Sequencing based on the rpoB gene and additional biochemical
analysis with malonate broth confirmed the identities of these two strains as Cr.
malonaticus. This PCR-RFLP assay is, therefore, an accurate typing method that ensures
rapid differentiation between the five species of Cronobacter.AFRIKAANSE OPSOMMING: Die Cronobacter genus (Enterobacter sakazakii) bevat opportunistiese patogene wat 'n
ernstige vorm van neonatale meningitis, enterokolitis en septisemie kan veroorsaak.
Cronobacter infeksies is al in alle ouderdomsgroepe aangemeld, maar
immuungekompromitteerde babas is die meeste vatbaar vir hierdie infeksies. Verder toon
Cronobacter spesies verskille in virulensie en sensitiwiteit vir antibiotika. Hierdie verskille
het gelei tot die herklassifikasie van Cronobacter en tans bestaan die genus uit vyf
afsonderlike spesies, naamlik Cronobacter sakazakii, Cronobacter malonaticus,
Cronobacter turicensis, Cronobacter dublinensis en Cronobacter muytjensii. Aangesien
hierdie herklassifikasie slegs onlangs aanvaar is, is daar nie baie metodes wat geskik is vir
onderskeiding tussen die vyf Cronobacter spesies nie. Onderskeiding tussen Cronobacter
spesies is belangrik omdat die spesies verskillend kan wees met betrekking tot hulle
virulensie.
Cronobacter is geisoleer uit baba formule melk (BFM), die omgewing van 'n BFM
fabriek en vars produkte in Suid-Afrika. Daar is egter nie baie bekend oor die filogenie en
voorkoms van hierdie isolate nie. Die doel van hierdie studie was om 24 Suid-Afrikaanse
Cronobacter stamme (voorheen geïdentifiseer as E. sakazakii) te klassifiseer en die
filogenie van die isolate te evalueer gebaseer op die 16S ribosomale RNS (rRNS) en rpoA
gene. Al 24 Suid-Afrikaanse stamme is geïdentifiseer as Cr. sakazakii ten spyte van 'n
wye verskeidenheid isolasie bronne. Ander studies het ook gevind dat, ongeag die isolasie
bron, die meerderheid van Cronobacter stamme as Cr. sakazakii geïdentifiseer word. In
hierdie studie is gevind dat die Suid-Afrikaanse stamme filogeneties nou verwant is. Op
grond van die 16S rRNA geen analise is die Cr. sakazakii stamme egter in twee
afsonderlike groepe gedeel met 'n 93% vertrouens vlak.
Dit was moontlik om stamme van Cr. sakazakii, Cr. dublinensis, Cr. turicensis en Cr.
muytjensii van mekaar te onderskei met die DNS volgorde data van die 16S rRNA en rpoA
gene, maar geen onderskeid tussen Cr. sakazakii en Cr. malonaticus stamme was
moontlik nie. Die filogram gebaseer op die rpoA DNS volgorde data het aparte takke vir Cr.
malonaticus en Cr. sakazakii stamme getoon, maar die twee takke is met ‘n lae vertrouens
waarde van slegs 70 % geskei. Filogenetiese analise gebaseer op die rpoA en 16S rRNA
gene is dus nie voldoende om te onderskei tussen al die Cronobacter spesies nie. Die
DNS volgorde data van hierdie twee gene sou egter gebruik kon word om te onderskei
tussen die Cronobacter spesies wanneer dit gebruik word in kombinasie met
malonaatbenutting-analises.
'n Polimerase ketting reaksie (PKR) beperkings fragment lengte polimorfisme
(BFLP) metode is ontwikkel om die gelyktydige onderskeiding tussen al vyf Cronobacter
spesies te fasiliteer. Die PKR-BFLP metode is gebaseer op die vermeerdering van die
rpoB geen gevolg deur die gesamentlike vertering met die beperkingsensieme, Csp6I en
HinP1I. Unieke profiele vir elk van die vyf Cronobacter spesies is verkry en dit was ook
moontlik om tussen Enterobacteriaceae en Cronobacter spesies te onderskei. Verder het
twee stamme wat as Cr. sakazakii geïdentifiseer is met DNS volgordebepaling van die 16S
rRNA en rpoA gene, PKR-BFLP profiele identies aan dié van Cr. malonaticus getoon.
DNS volgordebepaling van die rpoB geen en ‘n addisionele biochemiese toets met
malonaat sop het die identiteit van hierdie twee stamme as Cr. malonaticus bevestig.
Hierdie PKR-BFLP is dus 'n akkurate metode wat vinnige onderskeid tussen die vyf
spesies van Cronobacter kan verseker
Genomic and One Health investigation of SARS-CoV-2 in South African lions
https://drive.google.com/file/d/1jppWJORR_Hy6pJdkbp2Caj9H-cCliu7-/view?usp=sharinghttps://drive.google.com/drive/folders/1_TI7LNGvANft9hCQs9as-VABFolPkGdH?usp=sharinghttps://drive.google.com/drive/folders/1xQ3aGfmLV2f1d60SCSAb0CfRI0E1WL3P?usp=sharin